Related Experiment Videos

[Preoperative plasmapheresis for lung cancer with multiple myeloma]

T Tagawa1, S Itoh, I Sano

  • 1Department of Surgery, Kitakyushu City Yahata Hospital, Fukuoka, Japan.

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai
|December 1, 1995
PubMed

Insights

This case study highlights a patient with multiple myeloma and lung cancer who underwent surgery. Plasmapheresis improved coagulation but did not fully resolve bleeding issues, suggesting further research is needed.

Area of Science:

  • Oncology
  • Hematology
  • Surgical Oncology

Background:

  • Multiple myeloma and lung cancer are increasingly diagnosed together.
  • Patients may present with complex hematologic abnormalities complicating surgical management.

Observation:

  • A 66-year-old male with IgA kappa multiple myeloma and stage I lung cancer had impaired coagulation.
  • High IgA M protein levels suggested a risk of hyperviscosity syndrome.

Findings:

  • Plasmapheresis before pulmonary lobectomy improved coagulation parameters and reduced IgA M protein levels.
  • Despite plasmapheresis, postoperative bleeding occurred, attributed to pleural adhesions and myeloma-related bleeding tendency.

Implications:

  • Plasmapheresis may be considered for managing coagulation disorders in cancer patients with multiple myeloma undergoing surgery.
  • Further investigation is required to determine optimal plasmapheresis protocols and hematologic restoration goals in such cases.

Related Concept Videos